Search
Feed aggregator
GSK Reignites Blenrep Blockbuster Aspirations With Data from Phase III Studies
GSK Reignites Blenrep Blockbuster Aspirations With Data from Phase III Studies 6/18/2024
Roche Inks Potential $1.8B Deal With Ascidian to Develop RNA Exon Therapies
Roche Inks Potential $1.8B Deal With Ascidian to Develop RNA Exon Therapies 6/18/2024
Decheng Capital Eyes $700M Raise for Fifth Life Sciences Fund as VC Heats Up
Decheng Capital Eyes $700M Raise for Fifth Life Sciences Fund as VC Heats Up 6/18/2024
FDA Slaps BioNTech-MediLink ADC With Partial Clinical Hold Due to ‘Significant Risk of Illness’
FDA Slaps BioNTech-MediLink ADC With Partial Clinical Hold Due to ‘Significant Risk of Illness’ 6/17/2024
Takeda’s Epilepsy Drug Stumbles in Back-to-Back Phase III Rare Disease Failures
Takeda’s Epilepsy Drug Stumbles in Back-to-Back Phase III Rare Disease Failures 6/17/2024
Gilead’s Magrolimab Ineffective, Linked to Increase Risk of Death in MDS Patients
Gilead’s Magrolimab Ineffective, Linked to Increase Risk of Death in MDS Patients 6/17/2024
AstraZeneca’s Imfinzi Gets FDA Approval for Treating Endometrial Cancer
AstraZeneca’s Imfinzi Gets FDA Approval for Treating Endometrial Cancer 6/17/2024
Novo Nordisk CEO Agrees to Testify at Senate Hearing After Sanders’ Subpoena Threat
Novo Nordisk CEO Agrees to Testify at Senate Hearing After Sanders’ Subpoena Threat 6/17/2024
J&J’s $6.5B Momenta Buy Pays Off With Phase II Sjögren’s Disease Win
J&J’s $6.5B Momenta Buy Pays Off With Phase II Sjögren’s Disease Win 6/17/2024
Genetic Therapies Show Early Promise in Treating Obesity
Genetic Therapies Show Early Promise in Treating Obesity 6/17/2024
AI Enables Individualized Cancer Vaccines
AI Enables Individualized Cancer Vaccines 6/17/2024
FDA Action Alert: Merck, BMS, Sarepta and More
FDA Action Alert: Merck, BMS, Sarepta and More 6/17/2024
Opinion: Regulatory Flexibility Can Accelerate Rare Disease Drug Development
Opinion: Regulatory Flexibility Can Accelerate Rare Disease Drug Development 6/17/2024
Telix Abandons IPO Plans at Last Minute, Cites ‘Current Market Conditions’
Telix Abandons IPO Plans at Last Minute, Cites ‘Current Market Conditions’ 6/14/2024
J.P. Morgan Raises Over $500M for First Biotech Venture Capital Fund
J.P. Morgan Raises Over $500M for First Biotech Venture Capital Fund 6/14/2024
SCOTUS Upholds Access to Abortion Pill, Pharma Industry Applauds Court’s Ruling
SCOTUS Upholds Access to Abortion Pill, Pharma Industry Applauds Court’s Ruling 6/14/2024
GLP-1 Global Obesity Market to Reach $111B by 2033, Despite Headwinds: GlobalData
GLP-1 Global Obesity Market to Reach $111B by 2033, Despite Headwinds: GlobalData 6/14/2024
With Donanemab on the Cusp of Approval, Proper Alzheimer’s Diagnosis Is Urgent
With Donanemab on the Cusp of Approval, Proper Alzheimer’s Diagnosis Is Urgent 6/14/2024
BMS’ Augtyro Wins FDA Accelerated Approval for NTRK-Positive Solid Tumors
BMS’ Augtyro Wins FDA Accelerated Approval for NTRK-Positive Solid Tumors 6/14/2024
EU Says India’s Alchem Is Part of International Drug Price-Fixing Cartel
EU Says India’s Alchem Is Part of International Drug Price-Fixing Cartel 6/14/2024
World Pharma News
- AI-assisted approach identifies IRS4 as a promising drug target in multiple solid tumors
- Researchers identify natural compound that disarms drug-resistant bacteria
- Scientists discover a new way to make drug-resistant cancer treatable again
- A new drug concept to treat obesity and type 2 diabetes
- Autonomous AI-based drug prescribing rife with potential problems